New Delhi: Billionaire Mukesh Ambani’s group is getting into genetic mapping, looking to make a healthcare trend led by disruptive US startups like 23andMe more affordable and widespread in India’s growing consumer market, according to Economic Times.
Within weeks, the energy-to-ecommerce conglomerate will roll out a comprehensive Rs 12,000 ($145) genome sequencing test, Ramesh Hariharan, chief executive officer of Strand Life Sciences Pvt., which has developed the product was quoted as saying. Reliance Industries acquired the Bengaluru-based firm in 2021 and now owns about 80% of it.
The genome test, which is about 86% cheaper than other offerings available locally, can reveal a person’s predisposition to cancers, cardiac and neuro-degenerative ailments as well as identify inherited genetic disorders, he was quoted as saying.
Bhubaneswar: Affirming Prime Minister Narendra Modi’s resolve to ensure speedy development of railway sector in…
Bhubaneswar: Amid the rising mercury levels and thunderstorm activity in Odisha, the India Meteorological Department…
Bargarh: Police have detained eight youths in connection with the murder of an auto-rickshaw driver…
Bhubaneswar: BJP national president J P Nadda, and chief ministers of Uttar Pradesh and Assam…
Berhampur: Wile chicken is one of the cheapest sources of animal protein for common people,…
New Delhi: The Bharatiya Janata Party (BJP) has issued a show cause notice to former…
Bhubaneswar: A day after Prime Minister Narendra Modi raked up the issue of the missing…
Sambalpur: Mounting a stinging attack on Chief Minister Naveen Patnaik, BJP stalwart and Union Home…